Related references
Note: Only part of the references are listed.Recent progress towards clinically relevant ATP-competitive Akt inhibitors
Bayard R. Huck et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma
Tibor Bedekovics et al.
BLOOD (2016)
Overexpression of ubiquitin carboxyl terminal hydrolase-L1 enhances multidrug resistance and invasion/metastasis in breast cancer by activating the MAPK/Erk signaling pathway
Wenjuan Wang et al.
MOLECULAR CARCINOGENESIS (2016)
Deubiquitinating enzymes in cellular signaling and disease regulation
Pranita Hanpude et al.
IUBMB LIFE (2015)
UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α
Yoko Goto et al.
NATURE COMMUNICATIONS (2015)
Ubiquitin C-terminal hydrolase-L1 increases cancer cell invasion by modulating hydrogen peroxide generated via NADPH oxidase 4
Hyun Jung Kim et al.
ONCOTARGET (2015)
UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression
Sajjad Hussain et al.
ONCOTARGET (2015)
Akt and RhoA activation in response to high glucose require caveolin-1 phosphorylation in mesangial cells
Su-Zhen Wu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
The ubiquitin proteasome system and myocardial ischemia
Justine Calise et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance
Huang-Chun Lien et al.
HUMAN PATHOLOGY (2013)
Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients
Christine Schroeder et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Ubiquitin Hydrolase UCH-L1 Destabilizes mTOR Complex 1 by Antagonizing DDB1-CUL4-Mediated Ubiquitination of Raptor
Sajjad Hussain et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration
Kaya Bilguvar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
UCHL1 Is a Putative Tumor Suppressor in Ovarian Cancer Cells and Contributes to Cisplatin Resistance
Chengmeng Jin et al.
JOURNAL OF CANCER (2013)
A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells
Kyle J. Roux et al.
JOURNAL OF CELL BIOLOGY (2012)
The Ubiquitin Peptidase UCHL1 Induces G0/G1 Cell Cycle Arrest and Apoptosis Through Stabilizing p53 and Is Frequently Silenced in Breast Cancer
Tingxiu Xiang et al.
PLOS ONE (2012)
Critical phosphoprotein elements that regulate polymerase architecture and function in vesicular stomatitis virus
Amal A. Rahmeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation
Ramesh Ummanni et al.
MOLECULAR CANCER (2011)
The Tumor Suppressor UCHL1 Forms a Complex with p53/MDM2/ARF to Promote p53 Signaling and Is Frequently Silenced in Nasopharyngeal Carcinoma
Lili Li et al.
CLINICAL CANCER RESEARCH (2010)
The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling
S. Hussain et al.
LEUKEMIA (2010)
Ubiquitin carboxyl-terminal hydrolase L1 is required for maintaining the structure and function of the neuromuscular junction
Fujun Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
UCHL1 (PGP 9.5): Neuronal biomarker and ubiquitin system protein
Ian N. M. Day et al.
PROGRESS IN NEUROBIOLOGY (2010)
Comparative Proteomic Analysis of Osteosarcoma Cell and Human Primary Cultured Osteoblastic Cell
Xudong Liu et al.
CANCER INVESTIGATION (2009)
Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer
Y. Rebecca Chin et al.
CELLULAR SIGNALLING (2009)
Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis
H. J. Kim et al.
ONCOGENE (2009)
Useful markers for detecting minimal residual disease in cases of neuroblastoma
Susumu Ootsuka et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A
Aaron Leiblich et al.
PROSTATE (2007)
Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells
Qing-Quan Li et al.
CANCER SCIENCE (2007)
MAP kinase signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2007)
In vivo selection for metastasis promoting genes in the mouse
Kiranmai Gumireddy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel
George Z. Cheng et al.
CANCER RESEARCH (2007)
Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D
L. Hui et al.
ONCOGENE (2006)
Ubiquitin and ubiquitin-like proteins in cancer pathogenesis
Daniela Hoeller et al.
NATURE REVIEWS CANCER (2006)
Ubiquitin hydrolase Uch-L1 rescues β-amyloid-induced decreases in synaptic function and contextual memory
Bing Gong et al.
CELL (2006)
Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition
HY Irie et al.
JOURNAL OF CELL BIOLOGY (2005)
A genomic and functional inventory of deubiquitinating enzymes
SMB Nijman et al.
CELL (2005)
Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT
M Yoeli-Lerner et al.
MOLECULAR CELL (2005)
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors
SF Barnett et al.
BIOCHEMICAL JOURNAL (2005)
Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases
J Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer
V Vasko et al.
JOURNAL OF MEDICAL GENETICS (2004)
Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines
MM Schuierer et al.
CANCER RESEARCH (2004)
Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells
T Otsuki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg
A Ciechanover et al.
NEURON (2003)
A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
LD Mayo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production
D Kim et al.
FASEB JOURNAL (2001)
Ubiquitination and deubiquitination: Targeting of proteins for degradation by the proteasome
KD Wilkinson
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2000)
Share Paper
